380 related articles for article (PubMed ID: 34551699)
1. Effects of Histone Modification in Major Depressive Disorder.
Wu MS; Li XJ; Liu CY; Xu Q; Huang JQ; Gu S; Chen JX
Curr Neuropharmacol; 2022; 20(7):1261-1277. PubMed ID: 34551699
[TBL] [Abstract][Full Text] [Related]
2. Histone Modifications in Major Depressive Disorder and Related Rodent Models.
Deussing JM; Jakovcevski M
Adv Exp Med Biol; 2017; 978():169-183. PubMed ID: 28523546
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic modulation: Research progress on histone acetylation levels in major depressive disorders.
Meng Y; Du J; Liu N; Qiang Y; Xiao L; Lan X; Ma L; Yang J; Yu J; Lu G
J Drug Target; 2023 Feb; 31(2):142-151. PubMed ID: 36112185
[TBL] [Abstract][Full Text] [Related]
4. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.
Mathew OP; Ranganna K; Yatsu FM
Biomed Pharmacother; 2010 Dec; 64(10):733-40. PubMed ID: 20970954
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo.
Kelly RDW; Chandru A; Watson PJ; Song Y; Blades M; Robertson NS; Jamieson AG; Schwabe JWR; Cowley SM
Sci Rep; 2018 Oct; 8(1):14690. PubMed ID: 30279482
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylases (HDACs) as therapeutic target for depressive disorders.
Misztak P; Pańczyszyn-Trzewik P; Sowa-Kućma M
Pharmacol Rep; 2018 Apr; 70(2):398-408. PubMed ID: 29456074
[TBL] [Abstract][Full Text] [Related]
7. Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene.
Baldan F; Lavarone E; Di Loreto C; Filetti S; Russo D; Damante G; Puppin C
Mol Biol Rep; 2014 Aug; 41(8):5257-65. PubMed ID: 24844212
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
9. Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells.
Patzlaff JS; Terrenoire E; Turner BM; Earnshaw WC; Paulson JR
Exp Cell Res; 2010 Aug; 316(13):2123-35. PubMed ID: 20452346
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic DNA and histone modifications to treat kidney disease.
Fontecha-Barriuso M; Martin-Sanchez D; Ruiz-Andres O; Poveda J; Sanchez-Niño MD; Valiño-Rivas L; Ruiz-Ortega M; Ortiz A; Sanz AB
Nephrol Dial Transplant; 2018 Nov; 33(11):1875-1886. PubMed ID: 29534238
[TBL] [Abstract][Full Text] [Related]
11. Comparative Analysis of Post-Translational Modifications of Human Serum Albumin Derived from Human Plasma and Recombinant Sources in China.
Liu Q; Lin Z; Li C; Wang Z; Xu J; Cheng L; Ma L; Wang Z
Discov Med; 2024 May; 36(184):1054-1069. PubMed ID: 38798264
[TBL] [Abstract][Full Text] [Related]
12. Histone Modifications in Alzheimer's Disease.
Santana DA; Smith MAC; Chen ES
Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833274
[TBL] [Abstract][Full Text] [Related]
13. Updating a Strategy for Histone Deacetylases and Its Inhibitors in the Potential Treatment of Cerebral Ischemic Stroke.
Xu Y; Wang Q; Chen J; Ma Y; Liu X
Dis Markers; 2020; 2020():8820803. PubMed ID: 32963637
[TBL] [Abstract][Full Text] [Related]
14. Post-translational histone modifications and their interaction with sex influence normal brain development and elaboration of neuropsychiatric disorders.
Singh G; Singh V; Schneider JS
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):1968-1981. PubMed ID: 30315931
[TBL] [Abstract][Full Text] [Related]
15. [Histone modification and its application in therapy for hematologic malignancies -- review].
Fang MH; Ji XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):816-20. PubMed ID: 19549415
[TBL] [Abstract][Full Text] [Related]
16. The epigenetic code in depression: implications for treatment.
Schroeder M; Hillemacher T; Bleich S; Frieling H
Clin Pharmacol Ther; 2012 Feb; 91(2):310-4. PubMed ID: 22205200
[TBL] [Abstract][Full Text] [Related]
17. Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.
Bush EW; McKinsey TA
Circ Res; 2010 Feb; 106(2):272-84. PubMed ID: 20133912
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of memory by acetylation and methylation of chromatin: implications in neurological disorders, aging, and addiction.
Sen N
Neuromolecular Med; 2015 Jun; 17(2):97-110. PubMed ID: 24777294
[TBL] [Abstract][Full Text] [Related]
19. Role of Histone Deacetylases (HDACs) in Epilepsy and Epileptogenesis.
Citraro R; Leo A; Santoro M; D'agostino G; Constanti A; Russo E
Curr Pharm Des; 2017; 23(37):5546-5562. PubMed ID: 29076408
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.
Nightingale KP; Gendreizig S; White DA; Bradbury C; Hollfelder F; Turner BM
J Biol Chem; 2007 Feb; 282(7):4408-4416. PubMed ID: 17166833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
